Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11639381 Treatment of headache using anti-CGRP antibodies

Overview Structured Data Issues Contributors Activity

All edits

Edits on 14 Aug, 2023

"Add patent inventor"

Golden AI

edited on 14 Aug, 2023

Edits made to:

Infobox (+5 properties)

Infobox

Patent Inventor Names

Barbara Schaeffler0

Jeffrey T. L. Smith0

Joseph Hirman0

Lahar Mehta0

Roger K. Cady0

Edits on 3 May, 2023

"Created via: Entity Importer"

Golden AI

created this topic on 3 May, 2023

Edits made to:

Infobox (+18 properties)

Article (+161 characters)

‌

US Patent 11639381 Treatment of headache using anti-CGRP antibodies

Article

Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116393810

Date of Patent

May 2, 2023

Patent Application Number

167932080

Date Filed

February 18, 2020

Patent Citations

‌

US Patent 10066009 Anti-CGRP compositions and use thereof

‌

US Patent 10179809 Anti-CGRP compositions and use thereof

‌

US Patent 10189895 Anti-CGRP compositions and use thereof

‌

US Patent 10208112 Anti-CGRP compositions and use thereof

‌

US Patent 10214582 Anti-CGRP compositions and use thereof

‌

US Patent 10266587 Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers

‌

US Patent 10533048 Anti-CGRP compositions and use thereof

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11639381 Treatment of headache using anti-CGRP antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API